Literature DB >> 32811986

Informing single-arm clinical trials with external controls.

Ruthie Davi, Nirosha Mahendraratnam, Arnaub Chatterjee, C Jill Dawson, Rachel Sherman.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32811986     DOI： 10.1038/d41573-020-00146-5

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   112.288


× No keyword cloud information.
  5 in total

1.  Accelerating development of scientific evidence for medical products within the existing US regulatory framework.

Authors:  Rachel E Sherman; Kathleen M Davies; Melissa A Robb; Nina L Hunter; Robert M Califf
Journal:  Nat Rev Drug Discov       Date:  2017-02-24       Impact factor: 84.694

2.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.

Authors:  Peter C Austin
Journal:  Multivariate Behav Res       Date:  2011-06-08       Impact factor: 5.923

3.  Real-World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe.

Authors:  Alison Cave; Xavier Kurz; Peter Arlett
Journal:  Clin Pharmacol Ther       Date:  2019-04-10       Impact factor: 6.875

Review 4.  A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials.

Authors:  Michael J Grayling; Munyaradzi Dimairo; Adrian P Mander; Thomas F Jaki
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

5.  Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia.

Authors:  N Gökbuget; M Kelsh; V Chia; A Advani; R Bassan; H Dombret; M Doubek; A K Fielding; S Giebel; V Haddad; D Hoelzer; C Holland; N Ifrah; A Katz; T Maniar; G Martinelli; M Morgades; S O'Brien; J-M Ribera; J M Rowe; A Stein; M Topp; M Wadleigh; H Kantarjian
Journal:  Blood Cancer J       Date:  2016-09-23       Impact factor: 11.037
  5 in total
  2 in total

Review 1.  Leveraging external data in the design and analysis of clinical trials in neuro-oncology.

Authors:  Rifaquat Rahman; Steffen Ventz; Jon McDunn; Bill Louv; Irmarie Reyes-Rivera; Mei-Yin C Polley; Fahar Merchant; Lauren E Abrey; Joshua E Allen; Laura K Aguilar; Estuardo Aguilar-Cordova; David Arons; Kirk Tanner; Stephen Bagley; Mustafa Khasraw; Timothy Cloughesy; Patrick Y Wen; Brian M Alexander; Lorenzo Trippa
Journal:  Lancet Oncol       Date:  2021-10       Impact factor: 41.316

2.  External controls to improve on glioblastoma clinical trials.

Authors:  Annette M Molinaro
Journal:  Neuro Oncol       Date:  2022-02-01       Impact factor: 13.029
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.